Recursion Pharmaceuticals Inc

6 de nov. de 2026, 23:01 UTC

Recursion Pharmaceuticals, Inc. is trading higher in after-market hours, reaching its highest level since Friday's close.

5 de nov. de 2026, 23:22 UTC

Recursion Pharmaceuticals, Inc. is trading lower in after-market hours, in line with a broader market decline and losses in the ARK Genomic Revolution ETF (ARKG).

4 de nov. de 2026, 21:04 UTC

Recursion Pharmaceuticals shares are rising during Wednesday's session, following a broader biotechnology sector increase and strong gains in the SPDR S&P Biotech ETF.

3 de nov. de 2026, 23:01 UTC

Recursion Pharmaceuticals, Inc. is moving higher in after-market hours, reflecting broader market gains amid strong economic data influencing Federal Reserve policy.

2 de nov. de 2026, 23:02 UTC

Recursion Pharmaceuticals appointed Fred Hassan as Chair of the Board, effective October 31, 2026, and reported positive Phase 2 data for REC-4881.

31 de out. de 2026, 00:01 UTC

Recursion Pharmaceuticals, Inc. is trading lower in after-market hours, having declined from Friday's close amid volatility and stabilization near its one-month range.

30 de out. de 2026, 23:01 UTC

Recursion Pharmaceuticals, Inc. declined during after-market hours, with cumulative returns falling since Friday's close after briefly peaking earlier in the session.

29 de out. de 2026, 23:01 UTC

Recursion Pharmaceuticals, Inc. shares declined during after-market hours on Thursday, breaking a trend of higher daily closes established earlier in the week.

28 de out. de 2026, 23:02 UTC

Recursion Pharmaceuticals, Inc. is trading lower in after-market hours, reflecting the broader market's decline and retracing from an earlier session high.

27 de out. de 2026, 23:01 UTC

Recursion Pharmaceuticals, Inc. is declining in after-market hours, marking a significant retracement from recent highs after finishing higher for three consecutive sessions.

26 de out. de 2026, 20:07 UTC

Recursion Pharmaceuticals Inc shares are advancing, having reached an early peak but ultimately settling lower near the lower end of their one-month range.

24 de out. de 2026, 00:01 UTC

Recursion Pharmaceuticals Inc shares are trading lower in after-market hours, having retraced from a brief peak earlier in the session.

23 de out. de 2026, 23:01 UTC

Recursion Pharmaceuticals Inc is declining in after-market trading, remaining significantly below its 20-day moving average and near the lower end of its one-month range.

22 de out. de 2026, 23:02 UTC

Recursion Pharmaceuticals Inc is experiencing a significant decline in after-market trading, moving lower since Thursday's close and reaching its lowest point of the day.

21 de out. de 2026, 23:51 UTC

Recursion Pharmaceuticals Inc is trading lower in after-market hours, reflecting broader market trends and positioning below its 20-day moving average.

20 de out. de 2026, 23:02 UTC

Recursion Pharmaceuticals Inc shares are trading modestly lower in after-market hours, with approximately $561 million in cash at the end of the quarter.

19 de out. de 2026, 23:01 UTC

Recursion Pharmaceuticals Inc is advancing in after-market trading, maintaining an upward trajectory since Monday's close.

17 de out. de 2026, 00:01 UTC

Recursion Pharmaceuticals Inc shares advanced modestly higher during after-market hours on Friday, diverging from the recent trend of higher daily closes.

16 de out. de 2026, 23:06 UTC

Recursion Pharmaceuticals Inc shares are modestly higher in after-market trading.

15 de out. de 2026, 20:03 UTC

Recursion Pharmaceuticals announces a $200 million oversubscribed follow-on offering and positive updates on drug candidate REC-4881, achieving a 47% median reduction in polyp burden.

14 de out. de 2026, 23:01 UTC

Recursion Pharmaceuticals Inc is declining in after-market trading, aligning with broader market losses amid rising inflation concerns and geopolitical tensions affecting oil supply.

13 de out. de 2026, 23:06 UTC

Recursion Pharmaceuticals Inc is trading modestly higher in after-market hours following Tuesday's close.

12 de out. de 2026, 20:02 UTC

Recursion Pharmaceuticals Inc shares are sharply lower, continuing a downward trend since Friday, despite an early spike in today's trading session.

10 de out. de 2026, 00:01 UTC

Recursion Pharmaceuticals Inc shares advanced during after-market hours on Friday, despite earlier pulling back from a session high.

9 de out. de 2026, 23:01 UTC

Recursion Pharmaceuticals Inc is trading modestly higher in after-market hours, recovering from an earlier decline while remaining well above its 20-day moving average.

8 de out. de 2026, 20:01 UTC

Recursion Pharmaceuticals faces downward pressure amid significant insider transactions, including a 50k share sale by Director Borgeson Blake on October 6.

7 de out. de 2026, 23:05 UTC

Recursion Pharmaceuticals Inc is trading lower in after-market hours, continuing a trend of three consecutive sessions finishing lower since Wednesday's close.

6 de out. de 2026, 20:02 UTC

Recursion Pharmaceuticals Inc. shares fell amid sector declines, with attention on upcoming Phase 2 data for REC-4881 and ongoing trials for other candidates.

5 de out. de 2026, 23:01 UTC

Recursion Pharmaceuticals Inc is declining in after-market trading, continuing lower since Monday's close, despite remaining above its 20-day moving average.

2 de out. de 2026, 20:07 UTC

Recursion Pharmaceuticals Inc is trading higher, supported by a favorable market environment and positive sentiment following recent labor statistics.